• HeatTreatmentCongress 2017: an outstanding success

    HeatTreatmentCongress 2017: an outstanding success

    The HeatTreatmentCongress in Cologne from 25th - 27th October 2017 was an outstanding success. Thanks to all our customers for visiting the joint booth of the companies BMI, IVA Schmetz, Mahler and LOI Thermprocess.

  • Expert services and favourable spare parts

    Expert services and favourable spare parts

    You need a service or spare parts for your furnace? Contact our department.

    Our service for you!

HIGH-QUALITY SERVICE

  • BMI is a specialist in industrial furnaces manufacturing and our strong partner from France. The company offers a wide range of industrial furnaces for vacuum, low-pressure or plasma heat and thermochemical treatments.
  • IVA is specialized in engineering and manufacturing of energy efficient heat treatment equipment for almost every application purpose. The range of furnaces featuring economic efficiency and high cost-performance ratio, is offering solutions for multiple heat treatment processes.
  • Since 1945 Schmetz, headquarted in Menden, Germany, has been developing and optimising modern, environmentally friendly vacuum furnaces. Today SCHMETZ is a worldwide active leader in this technology with 75 people.

Mahler GMBH

For almost 60 years MAHLER Industrial Furnaces has been a synonym for innovative furnace systems in outstanding quality. The range of products reaches from standard belt furnaces with 150 - 1300 mm belt width to highly specialized roller hearth furnaces and bogie hearth furnaces. Pure hydrogen atmospheres up to 1300°C are possible as well as throughput capacities of about 2,500 kg/hour.

Company

CORPORATE GROUP

As the IVA Schmetz Group, we specialise in the development and manufacture of industrial furnaces and offer innovative and reliable solutions in this field. With over 70 years of experience, more than 400 employees at 5 locations and our 4 established brands, we are in a position to meet all customer requirements in the field of heat treatment.

No news available.